Viewing Study NCT04556266


Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2025-12-28 @ 9:19 AM
Study NCT ID: NCT04556266
Status: WITHDRAWN
Last Update Posted: 2025-05-13
First Post: 2020-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module